Title: Mortality rates and risk factors in 1,412 Japanese patients with decompensated hepatitis
C virus-related cirrhosis: A retrospective long-term cohort study
Version: 5 Date: 21 Mar 2021
Reviewer's report:
According to the authors' response, anti-viral therapy and hepatocellular do affect the survival
rates. But, the case number are too small to be presented as figures. Instead, these results are
stated and explained in discussion.  It is acceptable.
Title: Mortality rates and risk factors in 1,412 Japanese patients with decompensated hepatitis
C virus-related cirrhosis: A retrospective long-term cohort study
Version: 5 Date: 21 Mar 2021
Reviewer's report:
According to the authors' response, anti-viral therapy and hepatocellular do affect the survival
rates. But, the case number are too small to be presented as figures. Instead, these results are
stated and explained in discussion.  It is acceptable.
Please review this paper.
user
Title: Mortality rates and risk factors in 1,412 Japanese patients with decompensated hepatitis
C virus-related cirrhosis: A retrospective long-term cohort study
Version: 5 Date: 21 Mar 2021
Reviewer's report:
According to the authors' response, anti-viral therapy and hepatocellular do affect the survival
rates. But, the case number are too small to be presented as figures. Instead, these results are
stated and explained in discussion.  It is acceptable.
assistant